Page last updated: 2024-08-21

dicyandiamido and Lung Neoplasms

dicyandiamido has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CY; Cheng, CH; Chern, JH; Chuu, JJ; Huang, CH; Huang, ZN; Li, SL; Lien, HY; Lin, CC; Wu, YY	1

Other Studies

1 other study(ies) available for dicyandiamido and Lung Neoplasms

Article	Year
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer. Investigational new drugs, 2011, Volume: 29, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Bromodeoxyuridine; Carcinoembryonic Antigen; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Guanidines; Humans; In Situ Nick-End Labeling; Lung; Lung Neoplasms; Mice; Mice, Nude; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Survival Analysis	2011

Article

Year

Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.

Investigational new drugs, 2011, Volume: 29, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Bromodeoxyuridine; Carcinoembryonic Antigen; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Guanidines; Humans; In Situ Nick-End Labeling; Lung; Lung Neoplasms; Mice; Mice, Nude; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Survival Analysis

2011